The Canadian COVID‑19 Funded Research Database

Back to main page

Displaying 211 through 220 of 353 results (Download Results)

Show results per page

Comparative analyses of how SARS-CoV-2 variants of concern affect the host response in cells of the respiratory tract

Hobman, Tom C | University of Alberta | Operating Grant | $499,130

CIHR Alberta 2021

Identifying strategies to (re)build trust in Canadian social institutions and increase public acceptance of COVID‑19 countermeasures

Meyer, Samantha | University of Waterloo | Operating Grant | $216,403

CIHR Ontario 2021

The Canadian Respiratory Research Network Long COVID‑19 Study

Gershon, Andrea S | Sunnybrook Research Institute | Operating Grant | $500,000

CIHR Ontario 2021

Teasing apart the differential impact of variants of concern on COVID‑19 severity and health inequities: a population-based genomic epidemiological investigation in Ontario and British Columbia.

Sbihi, Hind | B.C. Centre for Disease Control | Operating Grant | $451,188

CIHR British Columbia 2021

COVID-19 Variant Supplement – Expression and Purification of COVID19 Virus Spike (S) Protein for Diagnostics and Vaccines

Richardson, Christopher D | Dalhousie University | Operating Grant | $50,000

CIHR Nova Scotia 2021

Variations on a theme: New approaches to examine SARS-CoV-2 variants and their ABO connections

West, Lori J | University of Alberta | Operating Grant | $482,935

CIHR Alberta 2021

COVID-19 Variant Supplement – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Lemieux, Joanne M | University of Alberta | Operating Grant | $50,000

CIHR Alberta 2021

Mental health in people at risk from COVID‑19 due to a pre-existing medical condition: longitudinal study of risk factors, outcomes, and the role of vaccination

Thombs, Brett D | Lady Davis Institute for Medical Research | Operating Grant | $174,374

CIHR Quebec 2021

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Bell, John C | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics

Haas, Kurt | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback